| Year |
Citation |
Score |
| 2023 |
Seymour ZA, Pinkawa M, Daignault-Newton S, Bosch W, Michalski JM, Gay H, Hamstra DA. A pooled long-term follow-up after radiotherapy for prostate cancer with and without a rectal hydrogel spacer: impact of hydrogel on decline in sexual quality of life. Frontiers in Oncology. 13: 1239104. PMID 37886176 DOI: 10.3389/fonc.2023.1239104 |
0.371 |
|
| 2022 |
Quinn TJ, Chapman D, Parzen J, Wahl DR, McNamara A, Dess R, Chan J, Feng F, Jackson WC, Hamstra D. Validation of the Combination Gleason Score as an Independent Favorable Prognostic Factor in Prostate Cancer Treated With Dose-Escalated Radiation Therapy. Practical Radiation Oncology. PMID 36503624 DOI: 10.1016/j.prro.2022.08.013 |
0.489 |
|
| 2022 |
Seymour ZA, Daignault-Newton S, McLaughlin PW, Sandler H, Jackson W, Johnson SB, Miller D, Wei J, Sanda M, Hamstra DA. Patient reported outcomes for quality of life (QOL) by Expanded Prostate Cancer Index (EPIC) on average 15 years post treatment. Clinical and Translational Radiation Oncology. 36: 56-62. PMID 35813938 DOI: 10.1016/j.ctro.2022.05.007 |
0.397 |
|
| 2022 |
Delaney RK, Sisco-Taylor BL, Wang X, Scherr K, Ubel PA, Haaland B, Kahn VC, Hamstra D, Wei JT, Madanay F, Davis JK, Greeno TU, Fagerlin A. Two Specialists, Two Recommendations: Discordance between Urologists' & Radiation Oncologists' Prostate Cancer Treatment Recommendations. Urology. PMID 35768027 DOI: 10.1016/j.urology.2022.06.009 |
0.332 |
|
| 2022 |
Rao A, Moka N, Hamstra DA, Ryan CJ. Co-Inhibition of Androgen Receptor and PARP as a Novel Treatment Paradigm in Prostate Cancer-Where Are We Now? Cancers. 14. PMID 35159068 DOI: 10.3390/cancers14030801 |
0.372 |
|
| 2021 |
Parzen JS, Hamstra DA. Patient-Reported Quality of Life During Prostate Cancer Radiation Therapy: Insights Into the Patient Experience. International Journal of Radiation Oncology, Biology, Physics. 110: 1129-1131. PMID 34171237 DOI: 10.1016/j.ijrobp.2021.02.028 |
0.425 |
|
| 2020 |
Thompson AB, Hamstra DA. Rectal Spacer Usage with Proton Radiation Therapy for Prostate Cancer. International Journal of Radiation Oncology, Biology, Physics. 108: 644-648. PMID 32976788 DOI: 10.1016/j.ijrobp.2020.05.034 |
0.46 |
|
| 2020 |
Seymour ZA, Hamstra DA, Daignault-Newton S, Bosch W, Michalski J, Gay HA, Pinkawa M. Long-term Follow-up After Radiotherapy for Prostate Cancer with and without Rectal Hydrogel Spacer: A Pooled Prospective Evaluation of Bowel Associated Quality of Life. Bju International. PMID 32333714 DOI: 10.1111/Bju.15097 |
0.45 |
|
| 2020 |
Hagan M, Kapoor R, Michalski J, Sandler H, Movsas B, Chetty I, Lally B, Rengan R, Robinson C, Rimner A, Simone C, Timmerman R, Zelefsky M, DeMarco J, Hamstra D, et al. VA-Radiation Oncology Quality Surveillance Program. International Journal of Radiation Oncology, Biology, Physics. PMID 31983560 DOI: 10.1016/J.Ijrobp.2019.08.064 |
0.306 |
|
| 2020 |
Quinn TJ, Daignault-Newton S, Bosch W, Mariados N, Sylvester J, Shah D, Gross E, Hudes R, Beyer D, Kurtzman S, Bogart J, Hsi RA, Kos M, Ellis R, Logsdon M, ... ... Hamstra DA, et al. Who Benefits From a Prostate Rectal Spacer? Secondary Analysis of a Phase III Trial. Practical Radiation Oncology. PMID 31978591 DOI: 10.1016/J.Prro.2019.12.011 |
0.489 |
|
| 2019 |
Quinn TJ, Hamstra D. Hypofractionation in Prostate Cancer Using Proton Beam. International Journal of Radiation Oncology, Biology, Physics. 105: 723-726. PMID 31655657 DOI: 10.1016/J.Ijrobp.2019.08.006 |
0.448 |
|
| 2019 |
Hamstra DA, Pugh SL, Lepor H, Rosenthal SA, Pienta KJ, Gomella L, Peters C, D'Souza DP, Zeitzer KL, Jones CU, Hall WA, Horwitz E, Pisansky TM, Souhami L, Hartford AC, et al. Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 31540746 DOI: 10.1016/J.Radonc.2019.08.020 |
0.401 |
|
| 2019 |
Quinn TJ, Almahariq MF, Siddiqui ZA, Thompson AB, Hamstra DA, Kabolizadeh P, Gowans KL, Chen PY. Trimodality therapy for atypical teratoid/rhabdoid tumor is associated with improved overall survival: A surveillance, epidemiology, and end results analysis. Pediatric Blood & Cancer. e27969. PMID 31464041 DOI: 10.1002/Pbc.27969 |
0.378 |
|
| 2019 |
Foster B, Jackson W, Foster C, Dess R, Abu-Isa E, McLaughlin PW, Merrick G, Hearn J, Spratt D, Liauw S, Hamstra D. Application of a Prognostic Stratification System for High-risk Prostate Cancer to Patients Treated With Radiotherapy: Implications for Treatment Optimization. American Journal of Clinical Oncology. PMID 30724780 DOI: 10.1097/Coc.0000000000000521 |
0.503 |
|
| 2019 |
Seymour ZA, Daignault S, Bosch W, Michalski JM, Hamstra DA, Pinkawa M. Long-term follow-up after radiotherapy for prostate cancer with and without rectal hydrogel spacer: A pooled prospective evaluation of quality of life. Journal of Clinical Oncology. 37: 39-39. DOI: 10.1200/Jco.2019.37.7_Suppl.39 |
0.492 |
|
| 2019 |
Seymour ZA, Pinkawa M, Daignault-Newton S, Bosch WR, Michalski JM, Hamstra DA. Long-term Follow-up after Radiotherapy for Prostate Cancer with and without Rectal Hydrogel Spacer: A Pooled Prospective Evaluation of Sexual Function of Men with Good Baseline Sexual Function International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.578 |
0.392 |
|
| 2018 |
Dignam JJ, Hamstra DA, Lepor H, Grignon D, Brereton H, Currey A, Rosenthal S, Zeitzer KL, Venkatesan VM, Horwitz EM, Pisansky TM, Sandler HM. Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1800154. PMID 30526194 DOI: 10.1200/Jco.18.00154 |
0.482 |
|
| 2018 |
Seymour Z, Hamstra D. Quality of life is not compromised with intensification of androgen therapy in recurrent prostate cancer. The Lancet. Oncology. PMID 30213450 DOI: 10.1016/S1470-2045(18)30567-9 |
0.504 |
|
| 2018 |
Michalski JM, Moughan J, Purdy J, Bosch W, Bruner DW, Bahary JP, Lau H, Duclos M, Parliament M, Morton G, Hamstra D, Seider M, Lock MI, Patel M, Gay H, et al. Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial. Jama Oncology. PMID 29543933 DOI: 10.1001/Jamaoncol.2018.0039 |
0.555 |
|
| 2018 |
Dess RT, Devasia TP, Aghdam N, Jackson WC, Soni PD, Smith CP, Mitchell AL, Suy S, Hamstra DA, Jolly S, Nguyen PL, Feng FY, Schipper MJ, Skolarus TA, Miller DC, et al. Patient-Reported Sexual Aid Utilization and Efficacy After Radiation Therapy for Localized Prostate Cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 29487023 DOI: 10.1016/J.Ijrobp.2018.01.055 |
0.471 |
|
| 2018 |
Litzenberg DW, Muenz DG, Archer PG, Jackson WC, Hamstra DA, Hearn JW, Schipper MJ, Spratt DE. Changes in Prostate Orientation Due to Removal of a Foley Catheter. Medical Physics. PMID 29474748 DOI: 10.1002/Mp.12830 |
0.475 |
|
| 2018 |
Jackson WC, Dess RT, Litzenberg DW, Li P, Schipper M, Rosenthal SA, Chang GC, Horwitz EM, Price RA, Michalski JM, Gay HA, Wei JT, Feng M, Feng FY, Sandler HM, ... ... Hamstra DA, et al. A multi-institutional phase 2 trial of prostate stereotactic body radiation therapy (SBRT) using continuous real-time evaluation of prostate motion with patient-reported quality of life. Practical Radiation Oncology. 8: 40-47. PMID 29304991 DOI: 10.1016/J.Prro.2017.08.004 |
0.544 |
|
| 2018 |
Yu JB, Hamstra D. Point: Which Treatment Modality for Localized Prostate Cancer Yields Superior Quality of Life: Radiotherapy or Prostatectomy? Quality of Life is Better After Modern Radiotherapy Compared With Surgery. Oncology (Williston Park, N.Y.). 31: 830-2, 835. PMID 29179251 |
0.315 |
|
| 2018 |
Hamstra DA, Daignault-Newton S, Bosch WR, Mariados NF, Sylvester JE, Gross ET, Shah DK, Kurtzman SM, Bogart JA, Hsi RA, Kos M, Ellis RJ, Logsdon MD, Zimberg SH, Forsythe K, et al. Who Benefits From a Prostate Rectal Spacer?: Secondary Analysis of Dosimetry and Bowel Quality of Life From a Phase III Trial International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.312 |
0.418 |
|
| 2018 |
Foster B, Jackson WC, Foster CC, Dess RT, Abu-Isa EI, McLaughlin PW, Merrick GS, Hearn JWD, Spratt DE, Liauw S, Hamstra DA. Application of a Prognostic Stratification System for High-Risk Prostate Cancer to Patients Treated with Radiation Therapy: Implications for Treatment Optimization International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.301 |
0.534 |
|
| 2017 |
Karsh L, Gross E, Pieczonka CM, Aliotta PJ, Skomra CJ, Ponsky LE, Nieh PT, Han M, Hamstra DA, Shore ND. Absorbable Hydrogel Spacer Use in Prostate Radiotherapy: A Comprehensive Review of Phase 3 Clinical Trial Published Data. Urology. PMID 29174940 DOI: 10.1016/J.Urology.2017.11.016 |
0.458 |
|
| 2017 |
Masi K, Archer P, Jackson W, Sun Y, Schipper M, Hamstra D, Matuszak M. Knowledge-based treatment planning and its potential role in the transition between treatment planning systems. Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists. 43: 251-257. PMID 29174796 DOI: 10.1016/J.Meddos.2017.10.001 |
0.346 |
|
| 2017 |
Hamstra DA, Mariados N, Sylvester J, Shah D, Gross E, Hudes R, Beyer D, Kurtzman S, Bogart J, Hsi RA, Kos M, Ellis R, Logsdon M, Zimberg S, Forsythe K, et al. Sexual quality of life following prostate intensity modulated radiation therapy (IMRT) with a rectal/prostate spacer: Secondary analysis of a phase III trial. Practical Radiation Oncology. PMID 28951089 DOI: 10.1016/J.Prro.2017.07.008 |
0.514 |
|
| 2017 |
Dess RT, Hartman HE, Aghdam N, Jackson WC, Soni PD, Abugharib AE, Suy S, Desai NB, Zumsteg ZS, Mehra R, Morgan TM, Feng FY, Hamstra DA, Schipper MJ, Collins SP, et al. Erectile Function after Stereotactic Body Radiotherapy for Localized Prostate Cancer. Bju International. PMID 28710895 DOI: 10.1111/Bju.13962 |
0.501 |
|
| 2017 |
Gay HA, Sanda MG, Liu J, Wu N, Hamstra DA, Wei JT, Dunn RL, Klein EA, Sandler HM, Saigal CS, Litwin MS, Kuban DA, Hembroff L, Regan MM, Chang P, et al. External Beam Radiation Therapy or Brachytherapy With or Without Short-course Neoadjuvant Androgen Deprivation Therapy: Results of a Multicenter, Prospective Study of Quality of Life. International Journal of Radiation Oncology, Biology, Physics. 98: 304-317. PMID 28463150 DOI: 10.1016/J.Ijrobp.2017.02.019 |
0.475 |
|
| 2017 |
Jackson WC, Desai N, Abugharib AE, Tumati V, Dess RT, Lee JY, Zhao SG, Soliman M, Folkert M, Laine A, Hannan R, Zumsteg ZS, Sandler H, Hamstra DA, Montgomery JS, et al. Anatomic Patterns of Recurrence Following Biochemical Relapse after Post-Prostatectomy Salvage Radiation Therapy: A Multi-Institutional Study. Bju International. PMID 28139024 DOI: 10.1111/Bju.13792 |
0.432 |
|
| 2017 |
Hamstra DA, Shah D, Kurtzman S, Sylvester J, Zimberg SH, Hudes RS, Karsh LI, Logsdon MD, Beyer D, Kos M, Hsi RA, Forsythe K, Soffen EM, Francke PM, Zhang H, et al. Evaluation of sexual function on a randomized trial of a prostate rectal spacer. Journal of Clinical Oncology. 35: 69-69. DOI: 10.1200/Jco.2017.35.6_Suppl.69 |
0.48 |
|
| 2017 |
Dess RT, Hartman HE, Soni PD, Jackson WC, Suy S, Abugharib A, Mehra R, Schipper M, Feng FY, Hamstra DA, Collins SP, Spratt DE. Poster ViewingErectile Function After Stereotactic Body Radiation Therapy for Prostate Cancer: A Validated Model-Based Comparison to Nerve-Sparing Prostatectomy, Conventional Radiation Therapy, and Brachytherapy International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.1148 |
0.507 |
|
| 2016 |
Jackson WC, Feng FY, Daignault S, Hussain M, Smith D, Cooney K, Pienta K, Jolly S, Hollenbeck B, Olson KB, Sandler HM, Ray ME, Hamstra DA. A phase 2 trial of salvage radiation and concurrent weekly docetaxel after a rising prostate-specific antigen level after radical prostatectomy. Advances in Radiation Oncology. 1: 59-66. PMID 28799570 DOI: 10.1016/J.Adro.2015.11.001 |
0.509 |
|
| 2016 |
Hamstra DA, Mariados N, Sylvester J, Shah D, Karsh L, Hudes R, Beyer D, Kurtzman S, Bogart J, Hsi RA, Kos M, Ellis R, Logsdon M, Zimberg S, Forsythe K, et al. Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III Trial. International Journal of Radiation Oncology, Biology, Physics. PMID 28209443 DOI: 10.1016/J.Ijrobp.2016.12.024 |
0.516 |
|
| 2016 |
Dess RT, Jackson WC, Suy S, Soni PD, Lee JY, Abugharib AE, Zumsteg ZS, Feng FY, Hamstra DA, Collins SP, Spratt DE. Predictors of multidomain decline in health-related quality of life after stereotactic body radiation therapy (SBRT) for prostate cancer. Cancer. PMID 28001303 DOI: 10.1002/Cncr.30519 |
0.53 |
|
| 2016 |
Upadhyaya SA, Koschmann C, Muraszko K, Venneti S, Garton HJ, Hamstra DA, Maher CO, Betz BL, Brown NA, Wahl D, Weigelin HC, DuRoss KE, Leonard AS, Robertson PL. Brainstem Low-Grade Gliomas in Children-Excellent Outcomes With Multimodality Therapy. Journal of Child Neurology. PMID 27810966 DOI: 10.1177/0883073816675547 |
0.358 |
|
| 2016 |
Pisansky TM, Agrawal S, Hamstra DA, Koontz BF, Liauw SL, Efstathiou JA, Michalski JM, Feng FY, Abramowitz MC, Pollack A, Anscher MS, Moghanaki D, Den RB, Stephans KL, Zietman AL, et al. Salvage Radiation Therapy Dose Response for Biochemical Failure of Prostate Cancer After Prostatectomy-A Multi-Institutional Observational Study. International Journal of Radiation Oncology, Biology, Physics. PMID 27745980 DOI: 10.1016/J.Ijrobp.2016.08.043 |
0.545 |
|
| 2016 |
Caffo O, Thompson C, De Santis M, Kragelj B, Hamstra DA, Azria D, Fellin G, Pappagallo GL, Galligioni E, Choudhury A. Concurrent gemcitabine and radiotherapy for the treatment of muscle-invasive bladder cancer: A pooled individual data analysis of eight phase I-II trials. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 27720221 DOI: 10.1016/J.Radonc.2016.09.006 |
0.355 |
|
| 2016 |
Jackson WC, Desai NB, Tumati V, Lee JY, Dess RT, Soni PD, Abugharib A, Hamstra DA, Hearn JW, Sandler HM, Zumsteg ZS, Montgomery J, Hollenbeck B, Miller D, Palapattu G, et al. Predictors of Rapid Treatment Failure After Postoperative Radiation Therapy: A Multicenter Study. International Journal of Radiation Oncology, Biology, Physics. 96: S184-S185. PMID 27675733 DOI: 10.1016/J.Ijrobp.2016.06.461 |
0.384 |
|
| 2016 |
Ramey SJ, Abramowitz MC, Moghanaki D, Agrawal S, Efstathiou JA, Pisansky TM, Michalski JM, Koontz BF, Hamstra DA, Feng FY, Liauw S, Anscher MS, Pollack A, Den RB, Stephans KL, et al. Benefit of Elective Nodal Irradiation and Androgen Deprivation Therapy with Postprostatectomy Salvage Radiation Therapy for Prostate Cancer. International Journal of Radiation Oncology, Biology, Physics. 96: S102. PMID 27675529 DOI: 10.1016/J.Ijrobp.2016.06.253 |
0.54 |
|
| 2016 |
Agrawal S, Stephenson AJ, Michalski J, Efstathiou JA, Pisansky TM, Feng F, Hamstra DA, Koontz BF, Liauw S, Abramowitz MC, Pollack A, Anscher MS, Moghanaki D, Den RB, Stephans KL, et al. Prostate Cancer-Specific Mortality and Survival Outcomes for Salvage Radiation Therapy After Radical Prostatectomy. International Journal of Radiation Oncology, Biology, Physics. 96: S101. PMID 27675527 DOI: 10.1016/J.Ijrobp.2016.06.251 |
0.53 |
|
| 2016 |
Jackson WC, Desai NB, Tumati V, Lee JY, Dess RT, Soni PD, Abugharib A, Hamstra DA, Hearn JW, Sandler HM, Zumsteg ZS, Montgomery J, Hollenbeck B, Palapattu G, Tomlins SA, et al. Anatomic Patterns of Recurrence Following Biochemical Relapse After Postprostatectomy Radiation Therapy: A Multi-institutional Study. International Journal of Radiation Oncology, Biology, Physics. 96: E234. PMID 27674133 DOI: 10.1016/J.Ijrobp.2016.06.1212 |
0.395 |
|
| 2016 |
Soni PD, Moraes FY, Jackson WC, Gadia R, Dess RT, Lee JY, Palapattu G, Tomlins SA, Mera R, Morgan T, Hearn JW, Sandler HM, Hamstra DA, Leite ET, Zumsteg ZS, et al. Multicenter Independent Validation of the Zumsteg-Spratt Risk Classification System of Intermediate- and High-Risk Men Treated With Dose-Escalated Radiation Therapy Without Androgen Deprivation Therapy. International Journal of Radiation Oncology, Biology, Physics. 96: E233. PMID 27674132 DOI: 10.1016/J.Ijrobp.2016.06.1209 |
0.421 |
|
| 2016 |
Dess RT, Jackson WC, Hamstra DA, Suy S, Lee JY, Zumsteg ZS, Sandler HM, Feng FY, Collins SP, Spratt DE. Prospective Patient-Reported Outcomes After Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer: Longitudinal Predictors of Potency Preservation. International Journal of Radiation Oncology, Biology, Physics. 96: E226. PMID 27674113 DOI: 10.1016/J.Ijrobp.2016.06.1194 |
0.546 |
|
| 2016 |
Lee JY, Daignault-Newton S, Heath G, Scarlett S, Sanda MG, Chang P, Regan MM, Michalski JM, Sandler HM, Feng FY, Kuban DA, Zietman AL, Ciezki JP, Kaplan ID, Crociani C, ... ... Hamstra DA, et al. Multinational Prospective Study of Patient-Reported Outcomes After Prostate Radiation Therapy: Detailed Assessment of Rectal Bleeding. International Journal of Radiation Oncology, Biology, Physics. PMID 27663760 DOI: 10.1016/J.Ijrobp.2016.07.038 |
0.52 |
|
| 2016 |
Chang P, Regan MM, Ferrer M, Guedea F, Patil D, Wei JT, Hembroff LA, Michalski JM, Saigal CS, Litwin MS, Hamstra DA, Kaplan ID, Ciezki JP, Klein EA, Kibel AS, et al. Relief of Urinary Symptom Burden after Primary Prostate Cancer Treatment. The Journal of Urology. PMID 27593476 DOI: 10.1016/J.Juro.2016.08.101 |
0.446 |
|
| 2016 |
Tendulkar RD, Agrawal S, Gao T, Efstathiou JA, Pisansky TM, Michalski JM, Koontz BF, Hamstra DA, Feng FY, Liauw SL, Abramowitz MC, Pollack A, Anscher MS, Moghanaki D, Den RB, et al. Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27528718 DOI: 10.1200/Jco.2016.67.9647 |
0.49 |
|
| 2016 |
Mak RH, Hunt D, Efstathiou JA, Heney NM, Jones CU, Lukka HR, Bahary JP, Patel M, Balogh A, Nabid A, Leibenhaut MH, Hamstra DA, Roof KS, Jeffrey Lee R, Gore EM, et al. Acute and late urinary toxicity following radiation in men with an intact prostate gland or after a radical prostatectomy: A secondary analysis of RTOG 94-08 and 96-01. Urologic Oncology. PMID 27381895 DOI: 10.1016/J.Urolonc.2016.04.015 |
0.533 |
|
| 2016 |
Spratt DE, Jackson WC, Abugharib A, Tomlins SA, Dess RT, Soni PD, Lee JY, Zhao SG, Cole AI, Zumsteg ZS, Sandler H, Hamstra D, Hearn JW, Palapattu G, Mehra R, et al. Independent validation of the prognostic capacity of the ISUP prostate cancer grade grouping system for radiation treated patients with long-term follow-up. Prostate Cancer and Prostatic Diseases. PMID 27215611 DOI: 10.1038/Pcan.2016.18 |
0.518 |
|
| 2016 |
Feng FY, Zhang Y, Kothari V, Evans JR, Jackson WC, Chen W, Johnson SB, Luczak C, Wang S, Hamstra DA. MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent Manner. Neoplasia (New York, N.Y.). 18: 213-222. PMID 27108384 DOI: 10.1016/J.Neo.2016.01.006 |
0.525 |
|
| 2016 |
Shilkrut M, McLaughlin PW, Merrick GS, Vainshtein JM, Hamstra DA. Treatment Outcomes in Very High-risk Prostate Cancer Treated by Dose-escalated and Combined-Modality Radiation Therapy. American Journal of Clinical Oncology. 39: 181-8. PMID 24517957 DOI: 10.1097/Coc.0000000000000043 |
0.492 |
|
| 2016 |
Hamstra DA, Mariados NF, Shah DK, Kurtzman SM, Sylvester JE, Zimberg SH, Hudes RS, Karsh L, Logsdon MD, Beyer DC, Kos M, Hsi RA, Forsythe K, Soffen EM, Francke PM, et al. Continued Benefit to Rectal Separation for Prostate RT: Final Results of a Phase III Trial International Journal of Radiation Oncology Biology Physics. 96: 939. DOI: 10.1016/J.Ijrobp.2016.09.050 |
0.435 |
|
| 2015 |
Koloff ZB, Hamstra DA, Wei JT, Montgomery JS, Tomlins SA, Wu AJ, Morgan TM, Siddiqui J, Paich K, Chinnaiyan AM, Feng FY, Weizer AZ, Kunju LP, Hollenbeck BK, Miller DC, et al. Impact of tertiary Gleason pattern 5 on prostate cancer aggressiveness: Lessons from a contemporary single institution radical prostatectomy series. Asian Journal of Urology. 2: 53-58. PMID 29264120 DOI: 10.1200/Jco.2014.32.4_Suppl.15 |
0.463 |
|
| 2015 |
Magers MJ, Zhan T, Udager AM, Wei JT, Tomlins SA, Wu AJ, Kunju LP, Lew M, Feng FY, Hamstra DA, Siddiqui J, Chinnaiyan AM, Montgomery JS, Weizer AZ, Morgan TM, et al. Clinicopathologic characteristics of anterior prostate cancer (APC), including correlation with previous biopsy pathology. Medical Oncology (Northwood, London, England). 32: 249. PMID 26442515 DOI: 10.1007/S12032-015-0693-9 |
0.436 |
|
| 2015 |
Bernat JK, Wittman DA, Hawley ST, Hamstra DA, Helfand AM, Haggstrom DA, Darwish-Yassine M, Skolarus TA. Symptom burden and information needs in prostate cancer survivors: a case for tailored long-term survivorship care. Bju International. PMID 26389529 DOI: 10.1111/Bju.13329 |
0.409 |
|
| 2015 |
Evans JR, Zhao S, Daignault S, Sanda MG, Michalski J, Sandler HM, Kuban DA, Ciezki J, Kaplan ID, Zietman AL, Hembroff L, Feng FY, Suy S, Skolarus TA, McLaughlin PW, ... ... Hamstra DA, et al. Patient-reported quality of life after stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and brachytherapy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 26276528 DOI: 10.1016/J.Radonc.2015.07.016 |
0.501 |
|
| 2015 |
Rosenthal SA, Hunt D, Sartor AO, Pienta KJ, Gomella L, Grignon D, Rajan R, Kerlin KJ, Jones CU, Dobelbower M, Shipley WU, Zeitzer K, Hamstra DA, Donavanik V, Rotman M, et al. A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902. International Journal of Radiation Oncology, Biology, Physics. PMID 26209502 DOI: 10.1016/J.Ijrobp.2015.05.024 |
0.493 |
|
| 2015 |
Mariados N, Sylvester J, Shah D, Karsh L, Hudes R, Beyer D, Kurtzman S, Bogart J, Hsi RA, Kos M, Ellis R, Logsdon M, Zimberg S, Forsythe K, Zhang H, ... ... Hamstra DA, et al. Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. 92: 971-7. PMID 26054865 DOI: 10.1016/J.Ijrobp.2015.04.030 |
0.523 |
|
| 2015 |
Jackson WC, Schipper MJ, Johnson SB, Foster C, Li D, Sandler HM, Palapattu GS, Hamstra DA, Feng FY. Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy. European Urology. PMID 26004800 DOI: 10.1016/J.Ijrobp.2013.06.405 |
0.459 |
|
| 2015 |
Zhao SG, Jackson WC, Kothari V, Schipper MJ, Erho N, Evans JR, Speers C, Hamstra DA, Niknafs YS, Nguyen PL, Schaeffer EM, Ross AE, Den RB, Klein EA, Jenkins RB, et al. High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancer. Prostate Cancer and Prostatic Diseases. PMID 25986914 DOI: 10.1016/J.Ijrobp.2015.07.339 |
0.367 |
|
| 2015 |
Liss AL, Abu-Isa EI, Jawad MS, Feng FY, Vance SM, Winfield RJ, Narayana V, Sandler HM, McLaughlin PW, Hamstra DA. Combination therapy improves prostate cancer survival for patients with potentially lethal prostate cancer: The impact of Gleason pattern 5. Brachytherapy. 14: 502-10. PMID 25911994 DOI: 10.1016/J.Brachy.2015.02.389 |
0.539 |
|
| 2015 |
Shumway DA, Hamstra DA. Ageism in the undertreatment of high-risk prostate cancer: how long will clinical practice patterns resist the weight of evidence? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 676-8. PMID 25559801 DOI: 10.1200/Jco.2014.59.4093 |
0.544 |
|
| 2015 |
Hamstra DA, Bae K, Hanks G, Hu C, Shipley WU, Pan CC, Roach M, Lawton CA, Sandler HM. Impact of biochemical failure classification on clinical outcome: a secondary analysis of Radiation Therapy Oncology Group 9202 and 9413. Cancer. 121: 844-52. PMID 25410885 DOI: 10.1002/Cncr.29146 |
0.418 |
|
| 2015 |
Hamstra DA, Johnson SB, Daignault S, Zikmund-Fisher BJ, Taylor JM, Larkin K, Wood A, Fagerlin A. The impact of numeracy on verbatim knowledge of the longitudinal risk for prostate cancer recurrence following radiation therapy. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 35: 27-36. PMID 25277673 DOI: 10.1177/0272989X14551639 |
0.539 |
|
| 2015 |
Martin NE, Massey L, Stowell C, Bangma C, Briganti A, Bill-Axelson A, Blute M, Catto J, Chen RC, D'Amico AV, Feick G, Fitzpatrick JM, Frank SJ, Froehner M, Frydenberg M, ... ... Hamstra D, et al. Defining a standard set of patient-centered outcomes for men with localized prostate cancer. European Urology. 67: 460-7. PMID 25234359 DOI: 10.1016/J.Eururo.2014.08.075 |
0.452 |
|
| 2015 |
Jackson WC, Johnson SB, Feng FY, Hamstra DA. Salvage Radiation Therapy Improves Metastasis-free Survival for Clinically Aggressive and Indolent Prostate Cancer Recurrences After Radical Prostatectomy. American Journal of Clinical Oncology. 38: 367-72. PMID 23822986 DOI: 10.1097/Coc.0B013E31829E17Db |
0.551 |
|
| 2015 |
Michalski JM, Moughan J, Purdy J, Bosch W, Bahary J, Lau HY, Duclos M, Parliament M, Morton G, Hamstra DA, Seider MJ, Lock M, Patel M, Vigneault E, Dignam J, et al. A randomized trial of 79.2Gy versus 70.2Gy radiation therapy (RT) for localized prostate cancer. Journal of Clinical Oncology. 33: 4-4. DOI: 10.1200/Jco.2015.33.7_Suppl.4 |
0.502 |
|
| 2015 |
Caffo O, Thompson C, Santis MD, Kragelj B, Hamstra DA, Azria D, Pappagallo G, Fellin G, Choudhury A. Concurrent gemcitabine (GEM) and radiotherapy (XRT) as organ-sparing treatment for muscle-infiltrating bladder cancer (MIBC): Preliminary results of a patient-based cumulative analysis of seven phase I-II trials. Journal of Clinical Oncology. 33: 306-306. DOI: 10.1200/Jco.2015.33.7_Suppl.306 |
0.323 |
|
| 2015 |
Lu L, Singhal U, Skolarus TA, Palapattu GS, Montgomery JS, Weizer AZ, Hollenbeck BK, Miller DC, McNamara A, Mehra R, Tomlins SA, Hamstra DA, Morgan TM, Feng FY. Prognostic significance of perineural invasion in localized prostate cancer. Journal of Clinical Oncology. 33: 30-30. DOI: 10.1200/Jco.2015.33.7_Suppl.30 |
0.553 |
|
| 2015 |
Caffo O, Thompson C, Santis MD, Kragelj B, Hamstra DA, Azria D, Pappagallo G, Fellin G, Choudhury A. Prognostic factors in muscle-infiltrating bladder cancer (MIBC) treated with an organ-sparing treatment with concurrent gemcitabine (GEM) and radiotherapy (XRT): Results of a patient-based cumulative analysis of seven phase I-II trials. Journal of Clinical Oncology. 33. DOI: 10.1200/Jco.2015.33.15_Suppl.E15529 |
0.326 |
|
| 2015 |
Masi K, Archer P, Hamstra D, Matuszak M. SU-E-T-530: Knowledge-Based Treatment Planning and Its Potential Role in the Transition Between Treatment Planning Systems Medical Physics. 42: 3457-3457. DOI: 10.1118/1.4924892 |
0.309 |
|
| 2015 |
Singhal U, Lu L, Skolarus T, Palapattu G, Montgomery J, Weizer A, Hollenbeck B, Miller D, Mehra R, Montie J, Tomlins S, Kunju L, Hamstra D, Feng F, Morgan T. PD43-12 EFFECT OF TREATMENT DELAY ON LONG-TERM OUTCOMES IN MEN UNDERGOING RADICAL PROSTATECTOMY FOR PROSTATE CANCER. Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.2571 |
0.417 |
|
| 2015 |
Singhal U, Lu L, Skolarus T, Palapattu G, Montgomery J, Weizer A, Hollenbeck B, Miller D, Chan J, Mehra R, Tomlins S, Hamstra D, Feng F, Morgan T. MP56-12 THE ROLE OF PERINEURAL INVASION AS A PROGNOSTIC TOOL IN PROSTATE CANCER. Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.2076 |
0.473 |
|
| 2015 |
Magers M, Zhan T, Udager A, Hollenbeck B, Wei J, Miller D, Montgomery J, Siddiqui J, Feng F, Hamstra D, Weizer A, Morgan T, Chinnaiyan A, Palapattu G, Jiang H, et al. MP48-17 ANTERIOR PROSTATE CANCER: CLINICOPATHOLOGIC CHARACTERIZATION WITH BIOPSY CORRELATION Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.1691 |
0.472 |
|
| 2015 |
Lee JY, Scarlett S, Daignault-Newton S, Sanda MG, Michalski JM, Sandler HM, Kuban DA, Zietman AL, Ciezki JP, Kaplan ID, McLaughlin W, Mantz CA, Finkelstein SE, Suy S, Collins SP, ... Hamstra DA, et al. Impact of Rectal Bleeding on Quality of Life Measures After Prostate Radiation Therapy: Comparison of the EPIC-26 and EPIC-CP Instruments International Journal of Radiation Oncology Biology Physics. 93. DOI: 10.1016/J.Ijrobp.2015.07.481 |
0.483 |
|
| 2015 |
Bruner DW, Deshmukh S, Michalski J, Purdy J, Bosch W, Bahary J, Patel M, Parliament M, Lock M, Lau H, Hamstra D, Fisher S, Souhami L, Kwok Y, Seider M, et al. Bowel and Bladder Function of Men on a Phase 3 Randomized Study of High Versus Standard Dose of 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 93: S199-S200. DOI: 10.1016/J.Ijrobp.2015.07.478 |
0.499 |
|
| 2015 |
Agrawal S, Pisansky TM, Hamstra DA, Liauw S, Koontz BF, Efstathiou JA, Michalski JM, Feng FY, Abramowitz MC, Pollack A, Anscher MS, Moghanaki D, Den RB, Stephans KL, Kattan M, et al. Dose Response for Salvage Radiation Therapy After Radical Prostatectomy in Margin-Positive Prostate Cancer International Journal of Radiation Oncology Biology Physics. 93. DOI: 10.1016/J.Ijrobp.2015.07.317 |
0.54 |
|
| 2015 |
Tendulkar RD, Agrawal S, Efstathiou JA, Pisansky TM, Michalski JM, Koontz BF, Hamstra DA, Feng FY, Liauw S, Abramowitz MC, Pollack A, Anscher MS, Moghanaki D, Den RB, Stephans KL, et al. Contemporary Update of a Multi-institutional Predictive Nomogram for Salvage Radiation Therapy After Prostatectomy International Journal of Radiation Oncology Biology Physics. 93. DOI: 10.1016/J.Ijrobp.2015.07.313 |
0.404 |
|
| 2015 |
Dess RT, Jackson WC, Suy S, Collins SP, Hamstra DA. Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer: Predicting Patient-Reported Sexual Function at 2 Years International Journal of Radiation Oncology Biology Physics. 93. DOI: 10.1016/J.Ijrobp.2015.07.1113 |
0.511 |
|
| 2015 |
Jackson W, Litzenberg D, Schipper M, Wei J, Rosenthal S, Chang G, Horwitz E, Li J, Michalski J, Gay H, Feng F, Sandler H, Wallace R, Hamstra D. A Multi-institutional Phase 2 Trial Assessing Quality of Life (QOL) After Electromagnetic Transponder Guided Prostate Stereotactic Body Radiation Therapy (SBRT) International Journal of Radiation Oncology*Biology*Physics. 93: E205-E206. DOI: 10.1016/J.Ijrobp.2015.07.1070 |
0.467 |
|
| 2015 |
Wahl D, McNamara A, Jackson W, Chan J, Feng F, Hamstra D. Validation of the Combination Gleason Score as an Independent Favorable Prognostic Factor in GS 7-10 Prostate Cancer Treated With Dose-Escalated Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 93: E190. DOI: 10.1016/J.Ijrobp.2015.07.1034 |
0.549 |
|
| 2014 |
Son CH, Hamstra DA, Feng FY, Liauw SL. High-risk Prostate Cancer Treated With Dose-escalated RT: An Analysis of Hormonal Therapy Use and Duration, and Prognostic Implications of PSA Nadir ≤0.2 to Select Men for Short-term Hormonal Therapy. American Journal of Clinical Oncology. PMID 25436827 DOI: 10.1097/Coc.0000000000000161 |
0.509 |
|
| 2014 |
Foster CC, Jackson WC, Foster BC, Johnson SB, Feng FY, Hamstra DA. Less advanced disease at initiation of salvage androgen deprivation therapy is associated with decreased mortality following biochemical failure post-salvage radiation therapy. Radiation Oncology (London, England). 9: 245. PMID 25424123 DOI: 10.1186/S13014-014-0245-Z |
0.443 |
|
| 2014 |
Johnson S, Jackson W, Speers C, Feng F, Hamstra D. A comprehensive assessment of the prognostic utility of the Stephenson nomogram for salvage radiation therapy postprostatectomy. Practical Radiation Oncology. 4: 422-9. PMID 25407865 DOI: 10.1016/J.Prro.2014.02.003 |
0.447 |
|
| 2014 |
Jackson WC, Johnson SB, Foster B, Foster C, Li D, Song Y, Vainshtein J, Zhou J, Hamstra DA, Feng FY. Combining prostate-specific antigen nadir and time to nadir allows for early identification of patients at highest risk for development of metastasis and death following salvage radiation therapy. Practical Radiation Oncology. 4: 99-107. PMID 24890350 DOI: 10.1016/J.Ijrobp.2013.06.996 |
0.536 |
|
| 2014 |
Shilkrut M, Wu A, Thomas DG, Hamstra DA. Expression of ribonucleoside reductase subunit M1, but not excision repair cross-complementation group 1, is predictive in muscle-invasive bladder cancer treated with chemotherapy and radiation. Molecular and Clinical Oncology. 2: 479-487. PMID 24772321 DOI: 10.3892/Mco.2014.264 |
0.353 |
|
| 2014 |
Chen RC, Hamstra DA, Sandler HM, Zietman AL. Complications of prostate cancer treatment. The Lancet. Oncology. 15: e150. PMID 24694635 DOI: 10.1016/S1470-2045(14)70126-3 |
0.482 |
|
| 2014 |
Hamstra DA, Chen RC. RE: Mortality after radical prostatectomy or external beam radiotherapy for localized prostate cancer. Journal of the National Cancer Institute. 106: djt463. PMID 24586102 DOI: 10.1093/jnci/djt463 |
0.365 |
|
| 2014 |
Stenmark MH, Conlon AS, Johnson S, Daignault S, Litzenberg D, Marsh R, Ritter T, Vance S, Kazzi N, Feng FY, Sandler H, Sanda MG, Hamstra DA. Dose to the inferior rectum is strongly associated with patient reported bowel quality of life after radiation therapy for prostate cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 110: 291-7. PMID 24507766 DOI: 10.1016/J.Radonc.2014.01.007 |
0.532 |
|
| 2014 |
Vainshtein JM, Schipper M, Vance S, Feng FY, Olson KB, Hamstra DA. Limitations of the Cancer of the Prostate Risk Assessment (CAPRA) Prognostic Tool for Prediction of Metastases and Prostate Cancer-specific Mortality in Patients Treated With External Beam Radiation Therapy. American Journal of Clinical Oncology. PMID 24487421 DOI: 10.1097/Coc.0000000000000037 |
0.554 |
|
| 2014 |
Hoppe BS, Michalski JM, Mendenhall NP, Morris CG, Henderson RH, Nichols RC, Mendenhall WM, Williams CR, Regan MM, Chipman JJ, Crociani CM, Sandler HM, Sanda MG, Hamstra DA. Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer. Cancer. 120: 1076-82. PMID 24382757 DOI: 10.1002/Cncr.28536 |
0.556 |
|
| 2014 |
King EA, Hanauer DA, Choi SW, Jong N, Hamstra DA, Li Y, Farley FA, Caird MS. Osteochondromas after radiation for pediatric malignancies: a role for expanded counseling for skeletal side effects. Journal of Pediatric Orthopedics. 34: 331-5. PMID 23965908 DOI: 10.1097/Bpo.0000000000000081 |
0.356 |
|
| 2014 |
Chang P, Regan M, Wei J, Hembroff L, Michalski J, Saigal C, Litwin MS, Hamstra D, Kaplan I, Ciezki J, Klein E, Kibel A, Pisters L, Kuban D, Wood D, et al. Mp51-10 Predictors Of Favorable Urinary Outcomes After Prostate Cancer Treatment The Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.1666 |
0.347 |
|
| 2014 |
Michalski JM, Moughan J, Purdy JA, Bosch WR, Bahary J, Lau H, Duclos M, Parliament M, Morton G, Hamstra DA, Seider M, Lock MI, Patel M, Vigneault E, Dignam J, et al. Initial Results of a Phase 3 Randomized Study of High Dose 3DCRT/IMRT versus Standard Dose 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer (RTOG 0126) International Journal of Radiation Oncology Biology Physics. 90: 1263. DOI: 10.1016/J.Ijrobp.2014.10.035 |
0.48 |
|
| 2014 |
Zhao S, Evans JR, Daignault-Newton S, Sanda MG, Michalski J, Sandler HM, Kuban DA, Ciezki JP, Kaplan ID, Zietman AL, Feng FY, Hembroff L, Suy S, Mantz CA, Collins S, ... Hamstra DA, et al. Early Quality of Life (QOL) Declines Correlate With Later QOL After Intensity Modulated Radiation Therapy, Low-Dose-Rate Brachytherapy, or Stereotactic Radiation for Prostate Cancer International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.473 |
0.486 |
|
| 2014 |
Zhou J, Daignault-Newton S, Miller D, Wei J, Dunn R, Johnson S, Jackson W, Imam H, Kazzi N, McLaughlin P, Sandler H, Sanda M, Hamstra D. Patient-Reported Outcomes for Quality of Life (QOL) by Expanded Prostate Cancer Index (EPIC) 15 Years Posttreatment International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.2086 |
0.447 |
|
| 2014 |
Liss AL, Evans C, Narayana V, Schipper MJ, Hamstra DA, McLaughlin P. Comparison of External Beam and Combination Therapy for Prostate Cancer: Patient-Reported Outcomes of Sexual Function With 5-Year Follow-up International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.193 |
0.456 |
|
| 2014 |
Shumway D, Daignault S, Feng F, Jackson W, Johnson S, Miller D, Wei J, Hamstra D. Is the Fear of Postprostatectomy Radiation Therapy Justified?: An Analysis of Patient-Reported Quality of Life Following Adjuvant or Salvage Radiation International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.1439 |
0.396 |
|
| 2014 |
Johnson S, Jackson WC, Speers C, Feng FY, Hamstra DA. A Comprehensive Assessment of the Prognostic Utility of the Stephenson Nomogram for Salvage Radiation Therapy Postprostatectomy International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.1438 |
0.396 |
|
| 2014 |
Jackson W, Feng FY, Daignault S, Hussain M, Smith D, Cooney K, Pienta K, Jolly S, Hollenbeck B, Olson KB, Sandler HM, Ray ME, Hamstra DA. A Phase 2 Trial of Salvage Radiation and Concurrent Weekly Docetaxel After Rising PSA Post–Radical Prostatectomy International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.1360 |
0.403 |
|
| 2014 |
Evans JR, Zhao S, Daignault-Newton S, Sanda M, Michalski J, Sandler HM, Kuban DA, Ciezki JP, Kaplan ID, Zietman AL, Hembroff L, Feng F, Suy S, Mantz CA, Collins S, ... Hamstra DA, et al. Comparative Effectiveness Analysis of Patient-Reported Quality of Life (QOL) After Stereotactic Body Radiation Therapy as Compared to Intensity Modulated Radiation Therapy or Low-Dose-Rate Brachytherapy up to 2 Years After Treatment International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.1300 |
0.414 |
|
| 2014 |
Liss A, Zhou J, Evans C, Murgic J, Narayana V, Hamstra DA, McLaughlin PW. Anatomic Variability of the Neurovascular Elements Defined by MRI Brachytherapy. 13. DOI: 10.1016/J.Brachy.2014.02.267 |
0.381 |
|
| 2014 |
Hamstra DA, Shilkrut M, McLaughlin PW, Merrick G. Continued Benefit to Local Control Even in Very High-Risk Prostate Cancer Brachytherapy. 13. DOI: 10.1016/J.Brachy.2014.02.252 |
0.468 |
|
| 2013 |
Conlon AS, Daignault S, Bassetti MF, Vance S, Marsh R, Litzenberg D, Ritter T, Feng FY, Sandler HM, Sanda MG, Hamstra DA. Prediction of patient-reported bowel quality of life (QOL) after dose-escalated radiation therapy (RT) for prostate cancer by rectal dosimetry. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 84. PMID 28137127 DOI: 10.1200/Jco.2013.31.6_Suppl.84 |
0.536 |
|
| 2013 |
Jackson WC, Song Y, Foster B, Li D, Foster C, Palapattu GS, Mehra R, Kunju P, Feng FY, Hamstra DA. Maximum tumor diameter as a predictor for outcome following salvage radiation for prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 78. PMID 28137099 DOI: 10.1200/Jco.2013.31.6_Suppl.78 |
0.541 |
|
| 2013 |
Johnson SB, Foster C, Li D, Foster B, Song Y, Sandler HM, Palapattu GS, Kunju P, Mehra R, Hamstra DA, Feng FY. Gleason pattern 5 as a pathologic predictor of recurrence, development of metastasis, and prostate cancer-specific death for patients receiving salvage radiation therapy following radical prostatectomy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 151. PMID 28136734 DOI: 10.1200/Jco.2013.31.6_Suppl.151 |
0.541 |
|
| 2013 |
Johnson SB, Foster B, Foster C, Song Y, Li D, Sandler HM, Palapattu GS, Hamstra DA, Feng FY. PSA doubling time of ≤6 months as the optimal cutoff for predicting clinically relevant outcomes for men receiving salvage radiation therapy post radical prostatectomy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 167. PMID 28136719 DOI: 10.1200/Jco.2013.31.6_Suppl.167 |
0.436 |
|
| 2013 |
Gay HA, Michalski JM, Hamstra DA, Wei JT, Dunn RL, Klein EA, Sandler HM, Saigal C, Litwin M, Kuban D, Hembroff L, Chang P, Sanda MG. Neoadjuvant androgen deprivation therapy leads to immediate impairment of vitality/hormonal and sexual quality of life: results of a multicenter prospective study. Urology. 82: 1363-8. PMID 24139340 DOI: 10.1016/J.Urology.2013.06.062 |
0.535 |
|
| 2013 |
Hamstra DA. Oncology scan--intermittent androgen deprivation and the randomized evidence. International Journal of Radiation Oncology, Biology, Physics. 87: 446-8. PMID 24075270 DOI: 10.1016/J.Ijrobp.2013.08.047 |
0.524 |
|
| 2013 |
Johnson SB, Jackson WC, Murgic J, Feng FY, Hamstra DA. Time to Nadir PSA: Of Popes and PSA-The Immortality Bias. American Journal of Clinical Oncology. PMID 24064749 DOI: 10.1097/Coc.0B013E3182A468B2 |
0.506 |
|
| 2013 |
Litzenberg DW, Gallagher I, Masi KJ, Lee C, Prisciandaro JI, Hamstra DA, Ritter T, Lam KL. A measurement technique to determine the calibration accuracy of an electromagnetic tracking system to radiation isocenter. Medical Physics. 40: 081711. PMID 23927308 DOI: 10.1118/1.4813910 |
0.341 |
|
| 2013 |
Johnson SB, Hamstra DA, Jackson WC, Zhou J, Foster B, Foster C, Song Y, Li D, Palapattu GS, Kunju L, Mehra R, Sandler H, Feng FY. Larger maximum tumor diameter at radical prostatectomy is associated with increased biochemical failure, metastasis, and death from prostate cancer after salvage radiation for prostate cancer. International Journal of Radiation Oncology, Biology, Physics. 87: 275-81. PMID 23886418 DOI: 10.1016/J.Ijrobp.2013.05.043 |
0.497 |
|
| 2013 |
Jackson WC, Johnson SB, Li D, Foster C, Foster B, Song Y, Schipper M, Shilkrut M, Sandler HM, Morgan TM, Palapattu GS, Hamstra DA, Feng FY. A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomy. Radiation Oncology (London, England). 8: 170. PMID 23835115 DOI: 10.1186/1748-717X-8-170 |
0.319 |
|
| 2013 |
Jackson W, Hamstra DA, Johnson S, Zhou J, Foster B, Foster C, Li D, Song Y, Palapattu GS, Kunju LP, Mehra R, Feng FY. Gleason pattern 5 is the strongest pathologic predictor of recurrence, metastasis, and prostate cancer-specific death in patients receiving salvage radiation therapy following radical prostatectomy. Cancer. 119: 3287-94. PMID 23821578 DOI: 10.1002/Cncr.28215 |
0.517 |
|
| 2013 |
Shilkrut M, McLaughlin PW, Merrick GS, Vainshtein JM, Feng FY, Hamstra DA. Interval to biochemical failure predicts clinical outcomes in patients with high-risk prostate cancer treated by combined-modality radiation therapy. International Journal of Radiation Oncology, Biology, Physics. 86: 721-8. PMID 23664325 DOI: 10.1016/J.Ijrobp.2013.03.028 |
0.517 |
|
| 2013 |
Hamstra DA, Conlon AS, Daignault S, Dunn RL, Sandler HM, Hembroff AL, Zietman AL, Kaplan I, Ciezki J, Kuban DA, Wei JT, Sanda MG, Michalski JM. Multi-institutional prospective evaluation of bowel quality of life after prostate external beam radiation therapy identifies patient and treatment factors associated with patient-reported outcomes: the PROSTQA experience. International Journal of Radiation Oncology, Biology, Physics. 86: 546-53. PMID 23561651 DOI: 10.1016/J.Ijrobp.2013.01.036 |
0.498 |
|
| 2013 |
Johnson S, Jackson W, Li D, Song Y, Foster C, Foster B, Zhou J, Vainshtein J, Feng F, Hamstra D. The interval to biochemical failure is prognostic for metastasis, prostate cancer-specific mortality, and overall mortality after salvage radiation therapy for prostate cancer. International Journal of Radiation Oncology, Biology, Physics. 86: 554-61. PMID 23561650 DOI: 10.1016/J.Ijrobp.2013.02.016 |
0.498 |
|
| 2013 |
Feng FY, Blas K, Olson K, Stenmark M, Sandler H, Hamstra DA. Retrospective evaluation reveals that long-term androgen deprivation therapy improves cause-specific and overall survival in the setting of dose-escalated radiation for high-risk prostate cancer. International Journal of Radiation Oncology, Biology, Physics. 86: 64-71. PMID 23462420 DOI: 10.1016/J.Ijrobp.2012.11.024 |
0.567 |
|
| 2013 |
Gray PJ, Paly JJ, Yeap BY, Sanda MG, Sandler HM, Michalski JM, Talcott JA, Coen JJ, Hamstra DA, Shipley WU, Hahn SM, Zietman AL, Bekelman JE, Efstathiou JA. Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer. Cancer. 119: 1729-35. PMID 23436283 DOI: 10.1002/Cncr.27956 |
0.51 |
|
| 2013 |
Hamstra DA, Stenmark MH, Ritter T, Litzenberg D, Jackson W, Johnson S, Albrecht-Unger L, Donaghy A, Phelps L, Blas K, Halverson S, Marsh R, Olson K, Feng FY. Age and comorbid illness are associated with late rectal toxicity following dose-escalated radiation therapy for prostate cancer. International Journal of Radiation Oncology, Biology, Physics. 85: 1246-53. PMID 23265567 DOI: 10.1016/J.Ijrobp.2012.10.042 |
0.541 |
|
| 2013 |
Shilkrut M, Merrick GS, McLaughlin PW, Stenmark MH, Abu-Isa E, Vance SM, Sandler HM, Feng FY, Hamstra DA. The addition of low-dose-rate brachytherapy and androgen-deprivation therapy decreases biochemical failure and prostate cancer death compared with dose-escalated external-beam radiation therapy for high-risk prostate cancer. Cancer. 119: 681-90. PMID 22893254 DOI: 10.1002/Cncr.27784 |
0.552 |
|
| 2013 |
Amro H, Hamstra DA, Mcshan DL, Sandler H, Vineberg K, Hadley S, Litzenberg D. The dosimetric impact of prostate rotations during electromagnetically guided external-beam radiation therapy. International Journal of Radiation Oncology, Biology, Physics. 85: 230-6. PMID 22554583 DOI: 10.1016/J.Ijrobp.2012.03.020 |
0.514 |
|
| 2013 |
Morgan T, Jackson WC, Johnson S, Miller DC, Montgomery JS, Montie JE, Weizer AZ, Skloarus TA, Hollenbeck BK, Palapattu GS, Hamstra DA, Feng FY. 1501 Establishing A Threshold For Psa Doubling Time In Predicting Outcomes Following Salvage Radiation Therapy The Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.2980 |
0.41 |
|
| 2013 |
Hoppe BS, Michalski JM, Mendenhall NP, Morris CG, Henderson RH, Nichols RC, Regan MM, Sandler HM, Sanda MG, Hamstra DA. Comparative Effectiveness Study of Proton Therapy Versus IMRT for Definitive Treatment of Prostate Cancer Based on Patient-Reported Outcomes International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.909 |
0.497 |
|
| 2013 |
Stenmark MH, Johnson S, Conlon AS, Dainault S, Marsh R, Ritter T, Litzenberg D, Sandler HM, Sanda MG, Hamstra DA. Dose to the Inferior Rectum Has the Strongest Association With Patient-Reported Bowel Quality of Life (QOL) After External Beam Radiation Therapy (EBRT) for Prostate Cancer International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.444 |
0.437 |
|
| 2013 |
Johnson S, Jackson WC, Foster C, Li D, Palapattu GS, Sandler HM, Feng FY, Hamstra DA. The Interval to Biochemical Failure Is Prognostic for Metastasis, Prostate Cancer-Specific, and Overall Mortality Following Salvage Radiation Therapy for Prostate Cancer International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.1040 |
0.467 |
|
| 2013 |
Johnson S, Jackson WC, Foster B, Song Y, Palapattu GS, Sandler HM, Hamstra DA, Feng FY. The Impact of Anticoagulant Use on Clinical Outcomes in Men Treated With Definitive and Salvage Radiation Therapy International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.1039 |
0.432 |
|
| 2012 |
Michalski JM, Sanda MG, Litwin MS, Ferrer M, Hamstra DA, Regan MM, Saigal C, Kwan L, Gao T, Klein EA, Kattan MW, Stephenson AJ. Nomogram predicting treatment-related bowel dysfunction for men with localized prostate cancer treated by radical prostatectomy (RP), external-beam radiotherapy (EBRT), and brachytherapy (PI). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 55. PMID 28146976 DOI: 10.1200/Jco.2012.30.34_Suppl.55 |
0.484 |
|
| 2012 |
Stenmark MH, Hamstra DA. Re: Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era: A. S. Kibel, J. P. Ciezki, E. A. Klein, C. A. Reddy, J. D. Lubahn, J. Haslag-minoff, J. O. Deasy, J. M. Michalski, D. Kallogjeri, J. F. Piccirillo, D. M. Rabah, C. Yu, M. W. Kattan And A. J. Stephenson; J Urol 2012; 187: 1259-1265. The Journal of Urology. 188: 2438-9; author reply. PMID 23088984 DOI: 10.1016/J.Juro.2012.08.032 |
0.416 |
|
| 2012 |
Shilkrut M, Feng F, Hamstra DA. General commentary to the "management of biochemical recurrence after primary localized therapy for prostate cancer" by darwish o. M. And raj g. V. Frontiers in Oncology. 2: 126. PMID 23061043 DOI: 10.3389/Fonc.2012.00126 |
0.503 |
|
| 2012 |
Murgic J, Stenmark MH, Halverson S, Blas K, Feng FY, Hamstra DA. The role of the maximum involvement of biopsy core in predicting outcome for patients treated with dose-escalated radiation therapy for prostate cancer. Radiation Oncology (London, England). 7: 127. PMID 22852797 DOI: 10.1186/1748-717X-7-127 |
0.544 |
|
| 2012 |
Vainshtein J, Abu-Isa E, Olson KB, Ray ME, Sandler HM, Normolle D, Litzenberg DW, Masi K, Pan C, Hamstra DA. Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy. Radiation Oncology (London, England). 7: 82. PMID 22681643 DOI: 10.1186/1748-717X-7-82 |
0.545 |
|
| 2012 |
Stenmark MH, Vineberg K, Ten Haken RK, Hamstra DA, Feng M. Dosimetric implications of residual seminal vesicle motion in fiducial-guided intensity-modulated radiotherapy for prostate cancer. Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists. 37: 240-4. PMID 22189029 DOI: 10.1016/J.Meddos.2011.09.002 |
0.504 |
|
| 2012 |
Litzenberg DW, Balter JM, Hadley SW, Hamstra DA, Willoughby TR, Kupelian PA, Djemil T, Mahadevan A, Jani S, Weinstein G, Solberg T, Enke C, Levine L, Sandler HM. Prostate intrafraction translation margins for real-time monitoring and correction strategies. Prostate Cancer. 2012: 130579. PMID 22111005 DOI: 10.1155/2012/130579 |
0.489 |
|
| 2012 |
Vance SM, Stenmark MH, Blas K, Halverson S, Hamstra DA, Feng FY. Percentage of cancer volume in biopsy cores is prognostic for prostate cancer death and overall survival in patients treated with dose-escalated external beam radiotherapy. International Journal of Radiation Oncology, Biology, Physics. 83: 940-6. PMID 22056069 DOI: 10.1016/J.Ijrobp.2011.09.005 |
0.504 |
|
| 2012 |
Kapadia NS, Olson K, Sandler HM, Feng FY, Hamstra DA. Interval to biochemical failure as a biomarker for cause-specific and overall survival after dose-escalated external beam radiation therapy for prostate cancer. Cancer. 118: 2059-68. PMID 22009287 DOI: 10.1002/Cncr.26498 |
0.515 |
|
| 2012 |
Chang P, Regan M, Stephenson A, Ferrer M, Wei J, Hembroff L, Suárez JF, Michalski J, Saigal C, Litwin M, Hamstra D, Kaplan I, Aronovitz J, Ciezki J, Klein E, et al. 694 Alleviation Versus Induction Of Urinary Obstruction Or Incontinence By Prostate Cancer Treatment The Pivotal Role Of Pretreatment Urinary Symptoms The Journal of Urology. 187. DOI: 10.1016/J.Juro.2012.02.777 |
0.343 |
|
| 2012 |
Shilkrut M, McLaughlin WP, Stenmark MH, Abu-Isa E, Vance SM, Sandler HM, Evans C, Feng FY, Merrick GS, Hamstra DA. The Addition of Low-dose-rate Brachytherapy and Androgen Deprivation Therapy Decreases Prostate Cancer Death Compared to Dose-escalated External Beam Radiation Therapy for High-risk Prostate Cancer International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.385 |
0.544 |
|
| 2012 |
Song Y, Bhalla R, Siddiqui J, Chinnaiyan AM, Hamstra DA, Mehra R, Kunju LP, Feng FY. ERG Gene Fusions as a Prognostic Tumor Biomarker in Prostate Cancer Patients Treated With Salvage Radiation Therapy International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.1034 |
0.545 |
|
| 2012 |
Gray PJ, Paly JJ, Yeap B, Sanda MG, Talcott JA, Sandler HM, Michalski JM, Hamstra DA, Bekelman JE, Efstathiou JA. Patient-reported Quality of Life in Prostate Cancer Patients Treated With 3D Conformal Intensity Modulated or Proton Beam Radiation Therapy International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.039 |
0.406 |
|
| 2011 |
Feng FY, Han S, Brenner C, Sabolch A, Hamstra DA, Lawrence TS, Chinnaiyan A. PARP inhibition reverses radiation resistance conferred by ETS fusions in prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 4545. PMID 28023391 DOI: 10.1200/Jco.2011.29.15_Suppl.4545 |
0.453 |
|
| 2011 |
Kapadia NS, Feng FY, Olson KB, Sandler HM, Hamstra DA. The interval to biochemical failure versus biochemical failure as predictors for cause specific and overall survival following dose-escalated external beam radiation therapy for prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 4585. PMID 28023308 DOI: 10.1200/Jco.2011.29.15_Suppl.4585 |
0.521 |
|
| 2011 |
Qian Y, Feng FY, Halverson S, Blas K, Sandler HM, Hamstra DA. Use of percent positive biopsy cores to predict prostate cancer-specific death in patients treated with dose-escalated radiotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 35. PMID 27968380 DOI: 10.1200/Jco.2011.29.7_Suppl.35 |
0.515 |
|
| 2011 |
Sabolch A, Feng FY, Daignault-Newton S, Halverson S, Blas K, Phelps L, Olson KB, Sandler HM, Hamstra DA. Using Gleason pattern 5 to refine risk stratification for prostate cancer patients treated with dose-escalated radiotherapy and androgen-deprivation therapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 15. PMID 27968317 DOI: 10.1200/Jco.2011.29.7_Suppl.15 |
0.528 |
|
| 2011 |
Alemozaffar M, Regan MM, Cooperberg MR, Wei JT, Michalski JM, Sandler HM, Hembroff L, Sadetsky N, Saigal CS, Litwin MS, Klein E, Kibel AS, Hamstra DA, Pisters LL, Kuban DA, et al. Prediction of erectile function following treatment for prostate cancer. Jama. 306: 1205-14. PMID 21934053 DOI: 10.1001/Jama.2011.1333 |
0.449 |
|
| 2011 |
Feng FY, Qian Y, Stenmark MH, Halverson S, Blas K, Vance S, Sandler HM, Hamstra DA. Perineural invasion predicts increased recurrence, metastasis, and death from prostate cancer following treatment with dose-escalated radiation therapy. International Journal of Radiation Oncology, Biology, Physics. 81: e361-7. PMID 21820250 DOI: 10.1016/J.Ijrobp.2011.04.048 |
0.558 |
|
| 2011 |
Halverson S, Schipper M, Blas K, Lee V, Sabolch A, Olson K, Sandler HM, Feng FY, Hamstra DA. The Cancer of the Prostate Risk Assessment (CAPRA) in patients treated with external beam radiation therapy: evaluation and optimization in patients at higher risk of relapse. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 101: 513-20. PMID 21703711 DOI: 10.1016/J.Radonc.2011.05.080 |
0.474 |
|
| 2011 |
Stenmark MH, Blas K, Halverson S, Sandler HM, Feng FY, Hamstra DA. Continued benefit to androgen deprivation therapy for prostate cancer patients treated with dose-escalated radiation therapy across multiple definitions of high-risk disease. International Journal of Radiation Oncology, Biology, Physics. 81: e335-44. PMID 21645976 DOI: 10.1016/J.Ijrobp.2011.04.037 |
0.559 |
|
| 2011 |
Galbán CJ, Chenevert TL, Meyer CR, Tsien C, Lawrence TS, Hamstra DA, Junck L, Sundgren PC, Johnson TD, Galbán S, Sebolt-Leopold JS, Rehemtulla A, Ross BD. Prospective analysis of parametric response map-derived MRI biomarkers: identification of early and distinct glioma response patterns not predicted by standard radiographic assessment. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 4751-60. PMID 21527563 DOI: 10.1158/1078-0432.Ccr-10-2098 |
0.353 |
|
| 2011 |
Sabolch A, Feng FY, Daignault-Newton S, Halverson S, Blas K, Phelps L, Olson KB, Sandler HM, Hamstra DA. Gleason pattern 5 is the greatest risk factor for clinical failure and death from prostate cancer after dose-escalated radiation therapy and hormonal ablation. International Journal of Radiation Oncology, Biology, Physics. 81: e351-60. PMID 21493015 DOI: 10.1016/J.Ijrobp.2011.01.063 |
0.516 |
|
| 2011 |
Hamstra DA, Bae K, Pilepich MV, Hanks GE, Grignon DJ, McGowan DG, Roach M, Lawton C, Lee RJ, Sandler H. Older age predicts decreased metastasis and prostate cancer-specific death for men treated with radiation therapy: meta-analysis of radiation therapy oncology group trials. International Journal of Radiation Oncology, Biology, Physics. 81: 1293-301. PMID 21458924 DOI: 10.1016/J.Ijrobp.2010.07.2004 |
0.542 |
|
| 2011 |
Qian Y, Feng FY, Halverson S, Blas K, Sandler HM, Hamstra DA. The percent of positive biopsy cores improves prediction of prostate cancer-specific death in patients treated with dose-escalated radiotherapy. International Journal of Radiation Oncology, Biology, Physics. 81: e135-42. PMID 21345617 DOI: 10.1016/J.Ijrobp.2011.01.007 |
0.539 |
|
| 2011 |
Raldow A, Hamstra DA, Kim SN, Yu JB. Adjuvant radiotherapy after radical prostatectomy: evidence and analysis. Cancer Treatment Reviews. 37: 89-96. PMID 20667660 DOI: 10.1016/J.Ctrv.2010.07.001 |
0.465 |
|
| 2011 |
Amro H, Hadley S, McShan D, Hamstra D, Sandler H, Vineberg K, Litzenberg D. TU‐G‐BRC‐04: The Dosimetric Impact of Prostate Rotations during Electromagnetically Guided External Beam Radiation Therapy Medical Physics. 38: 3781-3781. DOI: 10.1118/1.3613233 |
0.469 |
|
| 2011 |
Howell DD, Schipper MJ, Hamstra DA. Weekly On-Treatment Assessment of Genito-Urinary Symptoms Using a Modification of the AUA Symptom Index Worksheet for Patients Receiving Radiation for Prostate Cancer International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.677 |
0.457 |
|
| 2011 |
Vainshtein JM, Abu-Isa E, Olson K, Ray ME, Sandler HM, Normolle D, Pan C, Hamstra DA. Urethral Sparing Intensity Modulated Radiation Therapy (US-IMRT) Is Not Shown To Improve Urinary Quality of Life (QOL) in Low Risk Prostate Cancer (PCa): Results of a Randomized Phase II Trial International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.675 |
0.496 |
|
| 2011 |
Stenmark MH, Feng FY, Hamstra DA. Impact of Androgen Deprivation Therapy on Men with Intermediate Risk Prostate Cancer Treated with Dose Escalated Radiotherapy International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.663 |
0.544 |
|
| 2011 |
Abu-Isa EI, Jawad MS, Evans C, Geraghty G, Narayana V, Winfield RJ, Hamstra DA, McLaughlin PW. Combination Low Dose Rate Brachytherapy and External Beam Radiation Treatment in Patients with Intermediate and High Risk Prostate Cancer: Clinical Efficacy and Patient Reported Outcomes- The University of Michigan Experience International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.645 |
0.5 |
|
| 2011 |
Hamstra DA, Daignault S, Sandler HM, Hembroff L, Zietman AL, Kaplan I, Ciezki J, Kuban D, Michalski J, Sanda MG. Multi-institutional Prospective Evaluation of Bowel Quality of Life after Prostate External Beam Radiation Therapy Identifies Patient and Treatment Factors Associated with Patient Reported Outcomes International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.221 |
0.491 |
|
| 2011 |
Hamstra DA, Dignam J, Porter A, Hanks GE, Lawton C, Roach M, Sandler HM. Surrogate End-points for Prostate Cancer Specific Survival: Superiority of the Interval to Biochemical Failure: An Analysis of RTOG 9202 and 9413 International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.210 |
0.476 |
|
| 2011 |
Hamstra DA, Zhang Y, Feng FY, Bhojani SM, Sharma N. Prostate Cancer Radiation Enhancement Through mTOR Pathway Inhibition: The Role of Tumor and Vascular Compartments International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.170 |
0.479 |
|
| 2010 |
Raldow A, Hamstra DA, Kim S, Yu JB. Salvage external beam radiotherapy for prostate cancer after radical prostatectomy: current status and controversy. Oncology (Williston Park, N.Y.). 24: 692-700, 702. PMID 20718248 |
0.479 |
|
| 2010 |
Hamstra DA, Michalski JM, Roach M, Sandler HM. Do not count out external-beam radiation therapy for high-risk prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: e518-9; author reply. PMID 20660824 DOI: 10.1200/Jco.2010.28.9561 |
0.519 |
|
| 2010 |
Hamstra DA, Eisbruch A, Naidu MU, Ramana GV, Sunkara P, Campbell KC, Ross BD, Rehemtulla A. Pharmacokinetic analysis and phase 1 study of MRX-1024 in patients treated with radiation therapy with or without cisplatinum for head and neck cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 2666-76. PMID 20388849 DOI: 10.1158/1078-0432.Ccr-09-3318 |
0.396 |
|
| 2010 |
Tsien C, Galbán CJ, Chenevert TL, Johnson TD, Hamstra DA, Sundgren PC, Junck L, Meyer CR, Rehemtulla A, Lawrence T, Ross BD. Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 2293-9. PMID 20368564 DOI: 10.1200/Jco.2009.25.3971 |
0.369 |
|
| 2010 |
Olson KB, Daignault S, Hamstra DA, Pienta KJ. Hormonal manipulation of prostate cancer with sequential androgen blockade. Journal of Clinical Oncology. 28. DOI: 10.1200/Jco.2010.28.15_Suppl.E15033 |
0.504 |
|
| 2010 |
Galban CJ, Chenevert TL, Meyer CR, Tsien C, Lawrence TS, Hamstra DA, Junck L, Sundgren PC, Johnson TD, Rehemtulla A, Ross BD. Abstract 3754: A prospective imaging biomarker trial for early identification of GBM patients resistant to first line therapy Cancer Research. 70: 3754-3754. DOI: 10.1158/1538-7445.Am10-3754 |
0.383 |
|
| 2010 |
Tsien C, Galban CJ, Chenevert TL, Johnson TD, Hamstra DA, Sundgren PC, Junck L, Meyer CR, Rehemtulla A, Lawrence TS, Ross BD. Abstract 2698: The parametric response map as an imaging biomarker for identifying progression from pseudoprogression in glioma patients Cancer Research. 70: 2698-2698. DOI: 10.1158/1538-7445.Am10-2698 |
0.391 |
|
| 2010 |
Stenmark MH, Vineberg KA, Litzenberg DW, Hamstra DA, Feng M. Interfraction Seminal Vesicle Motion and Target Margin Assessment for Fiducial-Guided Intensity Modulated Radiotherapy for Prostate Cancer International Journal of Radiation Oncology Biology Physics. 78. DOI: 10.1016/J.Ijrobp.2010.07.877 |
0.455 |
|
| 2010 |
Halverson S, Schipper M, Blas K, Sabolch A, Olson K, Sandler HM, Feng FY, Hamstra DA. The CAPRA Score is Prognostic for Outcome in Patients Treated with Radiation Therapy for Prostate Cancer International Journal of Radiation Oncology Biology Physics. 78. DOI: 10.1016/J.Ijrobp.2010.07.790 |
0.56 |
|
| 2010 |
Blas K, Feng FY, Halverson S, Lee V, Sabolch A, Olson K, Sandler HM, Hamstra DA. Long-term Androgen Deprivation Therapy Improves Metastasis Free and Cause-specific Survival Even in the Setting of Dose Escalated Radiation for Localized Prostate Cancer International Journal of Radiation Oncology Biology Physics. 78. DOI: 10.1016/J.Ijrobp.2010.07.316 |
0.535 |
|
| 2010 |
Sabolch A, Brenner J, Ateeq B, Li Y, Yocum A, Davis M, Hamstra D, Chinnaiyan A, Lawrence T, Feng F. Targeted Radiosensitization of ETS Gene Fusion-Positive Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 78: S113. DOI: 10.1016/J.Ijrobp.2010.07.289 |
0.436 |
|
| 2009 |
Galbán CJ, Mukherji SK, Chenevert TL, Meyer CR, Hamstra DA, Bland PH, Johnson TD, Moffat BA, Rehemtulla A, Eisbruch A, Ross BD. A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy. Translational Oncology. 2: 184-90. PMID 19701503 DOI: 10.1593/Tlo.09175 |
0.344 |
|
| 2009 |
Wittmann D, Montie JE, Hamstra DA, Sandler H, Wood DP. Counseling patients about sexual health when considering post-prostatectomy radiation treatment International Journal of Impotence Research. 21: 275-284. PMID 19609297 DOI: 10.1038/Ijir.2009.32 |
0.525 |
|
| 2009 |
Galbán CJ, Chenevert TL, Meyer CR, Tsien C, Lawrence TS, Hamstra DA, Junck L, Sundgren PC, Johnson TD, Ross DJ, Rehemtulla A, Ross BD. The parametric response map is an imaging biomarker for early cancer treatment outcome. Nature Medicine. 15: 572-6. PMID 19377487 DOI: 10.1038/Nm.1919 |
0.309 |
|
| 2009 |
Litzenberg DW, Hadley SW, McShan DL, Balter JA, Hamstra DA, Levine L, Sandler HM. Prostate Margins for Daily Rotations and Residual Translations International Journal of Radiation Oncology Biology Physics. 75. DOI: 10.1016/J.Ijrobp.2009.07.715 |
0.443 |
|
| 2009 |
Contessa J, Wang G, Pienta K, Chinnaiyan A, Wei J, Hamstra D, Sandler H. Serum PDGF Decreases during Combined Radiation and Androgen Deprivation Therapy for Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 75: S305. DOI: 10.1016/J.Ijrobp.2009.07.701 |
0.54 |
|
| 2008 |
Hamstra DA, Lee KC, Moffat BA, Chenevert TL, Rehemtulla A, Ross BD. Diffusion magnetic resonance imaging: an imaging treatment response biomarker to chemoradiotherapy in a mouse model of squamous cell cancer of the head and neck. Translational Oncology. 1: 187-94. PMID 19043529 DOI: 10.1593/Tlo.08166 |
0.348 |
|
| 2008 |
Hamstra DA, Galbán CJ, Meyer CR, Johnson TD, Sundgren PC, Tsien C, Lawrence TS, Junck L, Ross DJ, Rehemtulla A, Ross BD, Chenevert TL. Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 3387-94. PMID 18541899 DOI: 10.1200/Jco.2007.15.2363 |
0.339 |
|
| 2008 |
Vuyyuri SB, Hamstra DA, Khanna D, Hamilton CA, Markwart SM, Campbell KC, Sunkara P, Ross BD, Rehemtulla A. Evaluation of D-methionine as a novel oral radiation protector for prevention of mucositis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 2161-70. PMID 18381958 DOI: 10.1158/1078-0432.Ccr-07-1954 |
0.333 |
|
| 2008 |
Spalding AC, Hamstra DA. Radiation therapy reduces local failure and improves overall survival in sPNET. Pediatric Blood & Cancer. 51: 148; author reply 14. PMID 18273871 DOI: 10.1002/Pbc.21513 |
0.39 |
|
| 2008 |
Hamstra DA, Galban CJ, Meyer CR, Sundgren PC, Tsien C, Lawrence TS, Junck L, Rehemtulla A, Chenevert TL, Ross BD. Early Multi-modality Functional MRI Predicts Patient Survival Independent of Radiographic Response in Patients with High Grade Glioma International Journal of Radiation Oncology Biology Physics. 72. DOI: 10.1016/J.Ijrobp.2008.06.789 |
0.308 |
|
| 2007 |
Hamstra DA. Primary radiotherapy for childhood ependymoma? The Lancet. Oncology. 8: 758-9; author reply . PMID 17765188 DOI: 10.1016/S1470-2045(07)70254-1 |
0.31 |
|
| 2006 |
Cao Y, Nagesh V, Hamstra D, Tsien CI, Ross BD, Chenevert TL, Junck L, Lawrence TS. The extent and severity of vascular leakage as evidence of tumor aggressiveness in high-grade gliomas. Cancer Research. 66: 8912-7. PMID 16951209 DOI: 10.1158/0008-5472.Can-05-4328 |
0.323 |
|
| 2006 |
Kaminski MS, Hamstra D, Estes J, Wahl R. The impact of FLIPI on outcome of frontline treatment with single-agent I-131 tositumomab for follicular lymphoma (FL) Journal of Clinical Oncology. 24: 7509-7509. DOI: 10.1200/Jco.2006.24.18_Suppl.7509 |
0.308 |
|
| 2006 |
Ross BD, Hamstra DA, Chenevert TL, Moffat BA, Johnson TD, Tsein C, Meyer CR, Mukherji S, Junck L, Rehemtulla A, Lawrence TS. Assessment of the functional diffusion map (fDM) as an imaging biomarker for early stratification of glioma clinical response Journal of Clinical Oncology. 24: 1518-1518. DOI: 10.1200/Jco.2006.24.18_Suppl.1518 |
0.316 |
|
| 2005 |
Hamstra DA, Chenevert TL, Moffat BA, Johnson TD, Meyer CR, Mukherji SK, Quint DJ, Gebarski SS, Fan X, Tsien CI, Lawrence TS, Junck L, Rehemtulla A, Ross BD. Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. Proceedings of the National Academy of Sciences of the United States of America. 102: 16759-64. PMID 16267128 DOI: 10.1073/Pnas.0508347102 |
0.314 |
|
| 2004 |
Hamstra DA, Dunn R, Wei J, Montie J, Sanda M, Sandler H. Cause-specific survival is high following radiotherapy or surgery for Gleason score 8–10 prostate cancer International Journal of Radiation Oncology Biology Physics. 60. DOI: 10.1016/J.Ijrobp.2004.06.192 |
0.481 |
|
| 2000 |
Stegman LD, Rehemtulla A, Hamstra DA, Rice DJ, Jonas SJ, Stout KL, Chenevert TL, Ross BD. Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy. Gene Therapy. 7: 1005-10. PMID 10871748 DOI: 10.1038/Sj.Gt.3301199 |
0.315 |
|
| 2000 |
Chinnaiyan AM, Prasad U, Shankar S, Hamstra DA, Shanaiah M, Chenevert TL, Ross BD, Rehemtulla A. Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy Proceedings of the National Academy of Sciences of the United States of America. 97: 1754-1759. PMID 10677530 DOI: 10.1073/Pnas.030545097 |
0.368 |
|
| 2000 |
Hamstra DA, Pagé M, Maybaum J, Rehemtulla A. Expression of endogenously activated secreted or cell surface carboxypeptidase A sensitizes tumor cells to methotrexate-alpha-peptide prodrugs. Cancer Research. 60: 657-65. PMID 10676650 |
0.594 |
|
| 1999 |
Hamstra DA, Rehemtulla A. Toward an enzyme/prodrug strategy for cancer gene therapy: endogenous activation of carboxypeptidase A mutants by the PACE/Furin family of propeptidases. Human Gene Therapy. 10: 235-248. PMID 10022548 DOI: 10.1089/10430349950019020 |
0.306 |
|
| 1999 |
Hamstra DA, Rice DJ, Pu A, Oyedijo D, Ross BD, Rehemtulla A. Combined radiation and enzyme/prodrug treatment for head and neck cancer in an orthotopic animal model Radiation Research. 152: 499-507. DOI: 10.2307/3580146 |
0.397 |
|
| Show low-probability matches. |